Split-liver transplantation (SLT) for saving 2 recipients is an important strategy to expand the deceased donor pool, especially in pediatric recipients. In general, livers are split into a left lateral section for a child and a right trisection (RTS) for an adult. However, SLTs should be cautiously considered because the RTS graft can be a marginal graft in adult recipients. For this reason, SLT is restricted to optimal donors in many countries, not to compromise the outcomes of SLT recipients relative to that of whole liver (WL) deceased donor liver transplantation (DDLT) in adults. (1) (2) (3) (4) (5) (6) (7) In the Scientific Registry of Transplant Recipients data and the Eurotransplant Liver Allocation System, the 5-year overall survival (OS) rates were 65%-74% and 74%-75% in SLT and WL-DDLT, respectively. (2, 6) The complication rates in technical aspects were higher or similar in SLT than those in WL-DDLT. (8) SLT itself is one of the most important factors of donor risk indices. (9) Considering the possibility of compromised outcomes in SLT, the risk factors affecting the survival outcomes of adult SLT should be renounced. In this regard, we should not only consider the donors' condition but also the matched recipients' condition.
Donor age and quality of the deceased donor's liver, as well as ischemia time, are usual concerns when we consider SLT. On the other hand, if the deceased donor's liver quality is optimal but the recipient is in poor condition with a high Model for End-Stage Liver Disease (MELD) score (6) or urgent status such as United Network for Organ Sharing (UNOS) status I-IIA, (7) then a marginal volume graft using RTS can cause small-for-size syndrome, leading to a difficult recovery for the patient, similar to that for living donor liver transplantation (LDLT). (10, 11) In many centers, the donor and graft condition for SLT recipients is restricted to younger and bigger donors and less damaged donor condition. However, the criteria for the recipient's condition are not well established. In order to improve the outcomes of SLT, matched recipients, similar age, donor-to-recipient weight ratio (DRWR), laboratory Model for End-Stage Liver Disease (L-MELD) score, and UNOS status would be important criteria to consider in addition to the center's experience and ischemia time.
In Korea, SLTs have several advantages compared with other countries in terms of in situ splitting and short ischemia time. (12) Because organ shortage is a serious issue in Korea just like in other Asian countries, more than 75% of LTs are performed with LDLTs. Thus, the transplant surgeons are well-versed with splitting the liver in situ, like in LDLTs. Second, the cold ischemia time (CIT) for DDLT is usually <10 hours because Korea is a small country. In addition, since 2011, because of several legal issues related to potential brain-dead donors being modified to favor organ donation by the Korean government, (13) the number of deceased donors has increased by more than 300 per year (Fig. 1A) , which in turn has increased the number of SLTs as well (Fig. 1B,C) . Although the increase is small relative to LDLT, it has been increasing steadily. However, to the best of our knowledge, there has been no report on the outcomes of Korean SLTs.
The aim of this study was to investigate the outcomes of adult SLT using a RTS graft compared with those of adult WL-DDLT. Furthermore, we analyzed the risk factors affecting graft survival rates and OS of adult SLT in Korea using national data. 
Patients and Methods
We retrospectively reviewed data of patients who received LTs from January 2005 to December 2014, from the Korean Network for Organ Sharing (KONOS) database. (14) Data of SLTs using RTS grafts in adults (RTS-SLT group) were obtained from the KONOS database. We excluded patients who underwent re-LT, patients who received hemiliver grafts rather than RTS grafts, and patients who underwent multiorgan transplantation (Fig. 2) . The primary endpoint was OS, and the secondary endpoint was rates of graft survival and technical complications in the RTS-SLT group. These endpoints were compared with those of adult WL-DDLTs (WT-DDLT group) in the Seoul National University Hospital (SNUH) during the same time period.
Estimated liver volume was calculated by the formula from Fu-Gui et al. (11, 508 × body weight + 334.024) in order to measure the calculated graft-to-recipient weight ratio (cGRWR), which is based on the WL, even for RTS-SLT. (15) We also used DRWR, which is used in KONOS to match recipients on the waiting list.
The receiver operating characteristic (ROC) curve was used to determine a cutoff value for the L-MELD and DRWR to predict OS (Fig. 3) . The cutoff value of the L-MELD score was 30 (area under the curve [AUC], 0.74; 95% confidence interval [CI], 0.623-0.865; sensitivity, 42.3%; specificity, 84.8%; P < 0.001) and that of DRWR was 1.0 (AUC, 0.64; 95% CI, 0.517-0.760; sensitivity, 54.8%; specificity, 63.6%; P = 0.03).
We performed an analysis of risk factors of graft failure and OS using recipient age (reference, ≤55 years old), body weight (DRWR, reference, >1.0), total ischemia time (reference, ≤360 minutes), L-MELD score without additional points for hepatocellular carcinoma (HCC; reference, ≤30), underlying disease (reference, nonmalignant), and donor age (reference, ≤40 years old).
The technical complications were investigated, and only major complications were noted. Vascular and biliary complications were defined as an abnormal liver function test and imaging clues of complications (ie, vascular stenosis, thrombosis, intrahepatic duct dilatation, extrahepatic fluid collection combined with bilirubin of fluid more than 2 times than the serum level). These were confirmed by an intervention, which indicates major complications (≥ grade 3A) of the Clavien-Dindo classification. (16) A bleeding complication required bleeding control by surgical or nonsurgical intervention (≥ grade 3A) of the Clavien-Dindo classification.
The causes of death were categorized into cardiovascular, infectious, neurologic, bleeding, cancer related, graft related, graft-versus-host disease (GVHD), and unknown.
SLT pOLiCY iN KOrEA
KONOS uses the same matching policy for a donor and an adult recipient for both WL-DDLT and SLT using DRWR. The splitting criteria adopted in Korea during the study period are described in Table 1 according to the KONOS policies. They included donor characteristics (donor age and weight, stable hemodynamics, and less use of amines) and pediatric recipient characteristics (recipient age, recipient weight, and graft type). The liver function test is used as a reference, but it is not an absolute contraindication for splitting. KONOS policies designating an SLT do not include the category for adult recipients, graft biopsy, and anatomical variation of a graft. All adult recipients on the waiting list could be candidates for a SLT as well as a WL-DDLT according to DRWR matching, blood type, and status of urgency based on KONOS status, (14) the status of which is similar to those of UNOS. Status 1 indicates a highly emergent situation without an underlying disease. Status 2A indicates acute-on-chronic state disease with high mortality rate including hepatic failure. Status 2B and 3 are chronic liver disease statuses according to the ChildPugh class and waiting time.
When the deceased donor's condition is suitable for SLT, KONOS allocates both an adult and a child candidate as SLT recipients according to these criteria. The assigned centers, informed of potential recipients, then determine if a RTS graft should be used for an adult recipient and a left lateral section graft for a child recipient.
SpLiT prOCEDUrE iN DONOrS
In situ splitting techniques like liver donor procedures are usually applied for SLT in Korea. The RTS graft usually preserves the inferior vena cava, celiac axis, main portal vein, and a common bile duct. For this reason, the technical issues of RTS DDLT are the same as those of WL-DDLT. In a left lateral section graft like for LDLT, the left hepatic vein, left and middle hepatic arteries, left portal vein, and the left bile duct are preserved. In terms of hepatic artery division, the left and middle hepatic arteries were preserved and reconstructed for left-sided liver grafts in SLTs. Although uncommon, an aberrant segmental artery for segment 2 or 3 may have arisen from the middle hepatic artery. The middle hepatic artery is important for monosegment LT in small children, especially in those undergoing SLTs without preoperative donor images.
STATiSTiCAL ANALYSiS
We used SPSS, version 23.0 for Windows (IBM, Armonk, NY) to perform data analysis. Student t test for numerical values and chi-square test for categorical values were used to compare between the 2 groups. The Cox regression model was used for risk factor analysis, and the Kaplan-Meier survival analysis was used for OS. Log-rank test was used for comparing survival between the 2 groups. P values <0.05 were considered statistically significant.
ETHiCS
This study followed the ethical guidelines of the Declaration of Helsinki and was approved by the institutional review board of SNUH (institutional review board number 1708-025-875). The need for informed consent was waived by the institutional review board. 
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Anonymized data were created for the study. Because of the sensitive nature of the data collected for this study, requests to access the data set from qualified researchers trained in human subject confidentiality protocols may be sent to the SNUH institutional review board at cris@bri.snuh.org.
Results

THE ANNUAL TrENDS OF LT AND THE prOpOrTiON OF SLTS iN KOrEA
The total number of LTs in Korea was 9925 from January 2005 to December 2014. The number of DDLTs and LDLTs were 2462 (24.8%) and 7463 (75.1%), respectively. The first SLT was performed in 2000 in Korea and the number of SLTs was 5 patients in 2005; this further increased to 20 patients in 2014. The proportion of SLTs was still <5% of the total number of DDLTs. The most common type of SLT was the adult with child pair (Fig. 1) .
DEMOGrApHiCS
For the 100 SLT donors during this period, the number of adult recipients was 107. Among these 107 recipients, the following 21 patients were excluded ( Fig. 2) : patients who underwent re-LT (n = 3) and patients who received a hemiliver graft (n = 18). Among the 322 WL-DDLT recipients in SNUH, we excluded 16 patients who underwent re-LT, and 3 patients who underwent simultaneous kidney transplantation (KT) and liver transplantation (LT). Finally, 86 patients who received a RTS graft and 303 patients who underwent WL-DDLT in SNUH were enrolled (Table 2) .
There was no difference in basic characteristics between the recipients (age, sex, body weight, KONOS status, and L-MELD score) and donors (sex, body weight, ischemia time, the estimated liver volume, cGRWR, and DRWR) in the 2 groups (P > 0.05).
Hepatitis B virus (HBV)-related cirrhosis was more common in the RTS-SLT group, and malignancy was more common in the WL-DDLT group (P < 0.001). The donor age was younger in the RTS-SLT group compared with that in the WL-DDLT group (25.2 ± 8.2 versus 42.7 ± 15.6 years; P < 0.001) because of age criteria for SLT. The number of donors aged ≤ 40 years was 84 (97.7%) in the RTS-SLT group and 119 (39.3%) in the WL-DDLT group (P < 0.001). The median follow-up period was 24.4 (0-131) months for the RTS-SLT group and 48.4 (0-135) months for the WL-DDLT group (P < 0.001).
SUrvivAL OUTCOMES AND riSK FACTOr ANALYSiS iN rTS-SLT COMpArED WiTH THE WL-DDLT GrOUp
The graft survival rate was not inferior in the RTS-SLT group (91.0%, 89.0%, 89.0% in 1-, 3-, and 5-year survival rates, respectively), compared with the WL-DDLT group (94.9%, 92.8%, and 92.8% in 1-, 3-, and 5-year survival rates, respectively; P = 0.29; Fig . 4A ). The rates of retransplantation following RTS-SLT and WL-DDLT were 2.3% (2 patients among 86 RTS-SLT patients) and 0.3% (1 patient among 303 WL-DDLT patients), respectively (P = 0.06). The reasons for retransplantation in the RTS-SLT group were 1 patient for hepatic artery thrombosis and 1 patient for primary nonfunction; in the WL-DDLT group, 1 patient was retransplanted for hepatic artery thrombosis.
There was no related factor affecting graft survival rate; recipient age > 55 years (P = 0.11), DRWR ≤ 1.0 (P = 0.39), total ischemia time > 360 minutes (P = 0.82), L-MELD > 30 (P = 0.33), malignant underlying liver disease (P = 0.14), and donor age > 40 years (P = 0.52) were not significant risk factors of OS in the RTS-SLT group.
OS was lower in the RTS-SLT group (69.8%, 65.5%, and 63.1% in 1-, 3-, and 5-year survival rates, respectively), compared with the WL-DDLT group (86.8%, 79.8%, and 79.3% in 1-, 3-, and 5-year survival rates, respectively; P < 0.001; Fig. 4B ). The graft-failure-free survival rate including both graft failure and death was lower in the RTS-SLT group (69.8%, 65.5%, and 63.1% in 1-, 3-, and 5-year survival rates, respectively), compared with the WL-DDLT (86.8%, 79.8%, and 79.3% in 1-, 3-, and 5-year survival rates, respectively; P < 0.001; Fig. 4C ). However, the late mortality rates after 3 months were not different between the The factors affecting OS in the RTS-SLT group are described in Table 3 . Recipient age of > 55 years, total ischemia time of > 360 minutes, malignant underlying liver disease, and donor age of > 40 years were not significant risk factors of OS in the RTS-SLT group (P > 0.05). However, DRWR ≤ 1.0 (OR, 2.255; 95% CI, 1.023-4.973; P = 0.04) and L-MELD score > 30 (OR, 2.328; 95% CI, 1.027-5.279; P = 0.04) were significant risk factors for OS. We performed subgroup analysis according to DRWR (reference, > 1.0) and L-MELD scores (reference, ≤ 30; Fig. 5 ). Regardless of L-MELD score, if the patient's DRWR was > 1.0 in the RST-SLT group, the OS was similar to that in the WL-DDLT group (Fig. 5C,D ; P < 0.05). 
TECHNiCAL COMpLiCATiONS
The major technical complications requiring an intervention in the RTS-SLT and WL-DDLT groups are described in Table 4 . The vascular complication rates, including hepatic artery (2.3% versus 2.0%; P > 0.99), hepatic vein (1.2% versus 2.3%; P = 0.69), and portal vein (1.2% versus 0.7%; P = 0.53), were similar in the RTS-SLT group and WL-DDLT group, respectively. The rates of biliary complications were similar in both groups (4.7% versus 5.0%; P > 0.99). The rates of intra-abdominal bleeding requiring intervention were comparable in both groups (5.8% versus 4.6%; P = 0.58).
CAUSE OF DEATH
The most common cause of death in the RTS-SLT group was infection (32.2%), with pneumonia claiming the largest proportion (19.3%); graft failure (29.0%) was the second most common cause (Table 5 ). In the WL-DDLT group, graft failure (33.3%) was the most common cause of death, and cancer was the second (23.3%), with HCC claiming the largest proportion (20.0%). Graft-related problems in both early and late periods were similar in both groups (P > 0.05). Early mortality rates were different between the 2 groups (Tables 4 and 6 ). Infection (36.4%) was the most common cause of early death, and graft failure (27.3%) was the second most common cause of early death in the RTS-SLT group. However, graft failure (40.7%) was the most common cause of early death, and infection (25.9%) was the second most common cause of early death in the WL-DDLT group.
Discussion
After the first SLT was performed in 1998 in Korea, (17) the number and proportion of SLTs have been increasing, although the overall number and proportion are still small. NOTE: Data are given as n (%). 
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KODA to obtain information on potential candidates as deceased donors. The second reason is that changes in the SLT policy expanded the donor organ pool of DDLTs in 2013. Since 2013, registration to the SLT waiting list was open to every potential pediatric recipient on the waiting list for DDLT (Table 1) . However, prior to 2013, a child could be listed as a SLT candidate only when the parents established reasons that they were unsuitable liver donors. (18) The upper limit of donor age in SLT was widened from 35 to 40 years, and the lower limit (≥10 years) was replaced by donor body weight ≥50 kg in 2014. Since then, the pediatric SLT proportion has increased up to 27.8% of total pediatric LTs in 2015 from 6.5% in 2005. According to the annual report of KONOS in 2015, the proportion of child recipients was approximately 2.1% (88-101 children per year) of the total waiting list of LTs in Korea. However, KONOS policy for SLT does not include an adult recipient's criteria, graft quality, and anatomical variation of a graft. Serum liver function test and biopsy results themselves are not contraindications for SLT. In Korea, when the donor's condition is matched to the SLT criteria, KONOS allocates this splittable donor to both adult and child candidates who have priority on the waiting list according to DRWR (range, 0.5-2.0).
In adult recipients, the physician's main concern would be that RTS-SLT grafts can have similar outcomes compared with those of WL-DDLT, considering a reduced volume of the graft and severity of the recipient's condition, although the donor's age is usually younger than that in WL-DDLT. (10, 11, 19) The RTS graft volume is approximately 80% of the WL and its functional volume is approximately 60%-70% of the WL because of ischemic changes in segment 4.
In this particular study, we compared the outcomes of RTS-SLT and WL-DDLT groups according to L-MELD score and DRWR. The RTS-SLT recipients with DRWR > 1.0, which means a similar-sized or bigger donor than the matched recipient, had a similar OS to that of WL-DDLT recipients, even in severely ill patients with MELD scores > 30. The RTS-SLT recipients with DRWR ≤ 1.0, which denotes a smaller donor than the recipient, had worse outcomes because the recipient had <60%-70% of the WL volume. This result was similar to that reported in another study performed in 2008 using UNOS data; cGRWR < 1.5% was a risk factor for graft survival and OS rates. (2) In our study, cGRWR > 1.8% showed a similar effect on OS, but it was not significant (P = 0.06). Furthermore, in real-life daily practice, we do not use cGRWR in cases for DDLT matching. Matching using DRWR, even in SLT patients, is the more feasible method and could provide information very quickly when patients were called as candidates for a RTS-SLT. For this reason, DRWR, which was more convenient for DDLT allocation than cGRWR in practice, was evaluated as a risk factor of OS in this study.
The risk factors affecting OS of the RTS-SLT group were DRWR ≤ 1.0 (odds ratio [OR], 2.255; 95% CI, 1.023-4.973; P = 0.04) and MELD score > 30 (OR, 2.328; 95% CI, 1.027-5.279; P = 0.04). The total ischemia time was not significant in the RTS-SLT group as described in Table 3 . This result could be related to the relatively short ischemia time (in this study, median 297 minutes in the RTS group and 262 minutes in the WL-DDLT group) in Korea compared with other countries, (2, 6, 7, 20, 21) and only a small portion (29.9% and 24.8%) of this study cohort had ischemia times of > 6 hours.
In this study, donor age had no impact on survival outcomes. This could also be related to the relatively short ischemia time and the small size cohort, as well as younger donor age criteria compared with other studies. (6, 7, 21) In Korea, we need more data to validate the age criteria (≤ 40 years old for a SLT donor), ie, if there is a good liver with sufficient volume for SLT, but the donor age is more than 40 years, can we consider this donor for SLT? Using feasibility data of older donor livers (including age > 60 years) (22, 23) along with development of perfusion technology, (24, 25) we can expand the donor pool of SLTs by relaxing the age criteria and strengthening the volume-matching criteria because recipients have short ischemia times in Korea. The ROC analysis of donor age suggested a cutoff of 20 years. However, although this age, ie, 20 years, would lead to best results, this has no statistical and clinical meaning in this analysis. Although the cutoff of 40 years was chosen arbitrarily, we did not change this because 40 years came from a preexisting guideline.
Most importantly, patient survival differed between the 2 groups, although the rate of graft failure did not. In particular, the early mortality rate was worse in the RTS-SLT group than that in the WL-DDLT group, although donor age in the RTS-SLT group was younger than that in the WL-DDLT group, in this study. The most common causes of death and early death within 3 months in the RTS-SLT group were infectious complications for both (29.0% and 36.4%), although there were 2 patients with unknown cause of death in the RTS-SLT group. Ross et al. (7) also reported in their multicenter Italian study that the most common cause of death was infectious complications followed by multiorgan failure in the extended right liver graft group, suggesting that these patients were likely not appropriate candidates for partial grafts. This finding can be in part related to the use of a relatively small graft with a severely inflamed segment, ie, ischemic segment 4, in very sick patients. (26, 27) In our study, more than half of the patients were status 1 and 2A. Thus, early mortality in the RTS-SLT group would be related to a relatively small graft with an ischemic segment 4 in very sick patients or patients with unresolved pretransplant infection in this study. Korean centers have been less experienced in SLTs. These selection problems can be resolved as a program moves along the learning curve; avoidance of other risk factors would also improve outcomes, ensuring sufficient graft volume (DRWR > 1.0) or selecting less sick patients (L-MELD score < 30). (28) On the other hand, in order to improve outcomes without amending KONOS policy, inflow modulation could be one option to improve the outcome of RTS-SLT with DRWR < 1.0, especially with no sufficient collateral. However, these procedures, which are performed in LDLTs using a small graft in adult recipients, (29, 30) are according to surgeons' preferences, outflow issues, the degree of portal hypertension, and the presence of collateral circulation which could reduce the portal pressure of a small graft. (31) (32) (33) It would require further study to apply in SLTs.
It is very difficult to obtain a new graft for retransplantation in Korea because of donor organ scarcity. Thus, there was a gap between the graft failure rate (10.5% and 6.6% following RTS-SLTs and WL-DDLTs, respectively) and the retransplantation rate (2.3% and 0.3%, respectively), and the retransplantation rates did not represent the graft failure rates. Our retransplantation rates are consistent with those previously reported following LDLTs or DDLTs (1.1%-2.9%) in large-volume centers of Korea. (34, 35) In this study, vascular and biliary complication rates were not different in the 2 groups. This is because the granularity of data from the national registry database may underestimate the true incidence in some parts. However, these lower complication rates might partly be the result of benefits of the same vascular anatomy to a whole liver, and younger ages of donors, (7, 12, 21, 36) and shorter ischemia time (7, 21, 36) compared with the other reports. The rates of technical complications in SLT have been reported as higher than WL-DDLT or similar to WL-DDLT in adjusted condition. (2, 7, 8, 36) These results would be related to complex anatomy, prolonged CIT, (21) and ex vivo procedures. (5) Even with anatomical variations, extensive experience in LDLTs and the in situ splitting procedure can overcome the technical issues. In Korea, every transplant surgeon performs the in situ splitting technique. Ex vivo splitting is very rarely performed in Korea. It is performed in cases of unpredictable and unstable donor condition during operation with rapid perfusion. In a systemic review and meta-analysis, Wan et al. (5) reported that biliary and vascular complications only increased after ex vivo SLT rather than in situ SLT. A clear advantage of one technique over the other regarding graft or even patient survival is yet to be shown. Recently, Andrassy et al. (6) reported that CIT was significantly longer in SLT patients (12.1 ± 3.3 hours) than in WL-DDLT patients (8.3 ± 2.8 hours) using an analysis of EURO Transplant data. CIT is a well-known risk factor of graft dysfunction, and in this EURO study, the total ischemia time was also a risk factor for patient survival. Despite these defects, ex vivo SLT is usually performed because of the lack of facilities at the donor hospitals and the complexity of the process of organ procurement, in which several teams from different countries have to travel under tight schedules for EURO Transplant. (6) In contrast, despite these difficult administrative issues, Ross et al. (7) reported that most splitting procedures (121 among 125 procedures) were performed in situ in their Italian multicenter study. Because Korea is a small country and only 20 SLTs per year were performed, in situ splits were performed by attending transplant surgeons from each recipient center.
The differences between the 2 groups were less volume, ischemic segment 4, and bare cut surface in the RTS-SLT graft. Although bile leak and liver abscess were rare complications in split and living donor LTs in Korea, bile leak and liver abscess might potentially contribute to infectious problems and early mortality. For this reason, graft volume issues remained and became exaggerated in the interpretation of OS-related factors. Small graft volume is a fundamental issue in LT, especially in severely ill patients with high MELD score and in urgent situations (ie, status 1 and 2A). On the other hand, the technical concerns are only applicable to pediatric patients with small and short left hepatic arteries. However, in situ splitting, which consists of transecting liver parenchyma, dividing the left side vasculatures and bile duct, and then performing ex vivo perfusion, allows the pediatric-side surgeon to leave
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Our cohort seems to be in a relatively poor situation compared with other groups receiving SLTs in recent reports. (7) More than half of the patients had urgent status (KONOS status 1 and 2A) in both the RTS-SLT (55.8%) and WL-DDLT (63.7%) groups, and more than 25% of patients in each group had MELD scores of >30. In Korea, recipients with urgent and/or high MELD status had no choice other than a split graft because of severe deceased organ shortage. In contrast to the recipient side, on the donor side, ischemia time is short, a splittable donor is young, and a split donor operation is mostly done by in situ techniques in Korea. We could not prohibit taking a split graft for very sick patients who cannot wait any longer for a WL, but we could change the allocation policy to obtain a bigger liver for patients who need a partial split graft. The cause of graft loss and patient death is likely multifactorial, and the effect of 1 risk factor can be minimized by controlling the others. Therefore, the presence of only 1 risk factor such as high MELD score or low DRWR should not rule out the use of SLTs. Better outcomes of RTS-SLTs could be achieved if we matched DRWR more carefully between donors and recipients for SLT in Korea.
In summary, the technical complication rates and the 5-year graft survival rates were not different between the RTS-SLT group and WL-DDLT group. The 5-year OS and graft-failure-free survival rate of the RTS-SLT group were worse than those of the WL-DDLT group. In the subgroup analysis, OS was not different between the 2 groups if the DRWR was >1.0, regardless of the L-MELD score.
A sufficient volume of the graft estimated from the matched DRWR could generate similar outcomes in RTS-SLT compared with WL-DDLT in adult recipients, even in recipients with poor conditions, ie, high MELD score. We need further data to validate these outcomes and to support modifying the matching policies.
the operating theater after ex vivo perfusion without waiting through the entire procedure.
This study has several limitations. First, several data were missing because of national data sources. This analysis shares the limitations inherent with all registry analyses, including partially incomplete data sets and loss of follow-up. Inclusion criteria and allocation data used cannot be extrapolated without caution because they are fundamentally related to the specific situation of Korea. However, this is the first report on outcomes of Korean adult SLT, even with a small number of SLT patients.
Second, the outcomes of the WL-DDLT group could be different from the national data because our institution is a large-volume LDLT center, which would have better survival outcomes. The national data of the 5-year OS following DDLT in Korea is 70.4% (KONOS data), (14) which was worse compared with those of the WL-DDLT group in this study. This rate was an old collection of data from the period since 2000 and included data from SLTs and retransplantations. On the other hand, Ross et al. (7) reported that center volume did not predict patient or graft survival in their multicenter Italian study; 75% of the patients in their study were treated by the 2 transplant centers defined as high-volume programs, and center volume did not predict patient or graft survival. Partial liver grafts of SLTs were accepted and performed mainly by high-volume transplant centers, and low-volume centers were likely to be more cautious regarding SLT recipient selection, which may have influenced their outcomes. In our study, the situation of center enrollment to SLTs was similar; 61.6% of patients were treated by several high-volume (> 50 LTs per year) centers and 14.0% were treated by medium-volume (25-50 LTs per year) centers. The center volume again had no impact on outcome of SLTs in our study (P = 0.53). Despite these potential biases, the survival outcome of RTS-SLT patients with DRWR > 1.0 was also similar to that of WL-DDLT patients in our institute, which is promising.
Third, this outcome represents a special situation in Korea; this study cohort had many benefits including relatively young donors, short ischemia time, and in situ splitting of grafts preserving the main vasculature to the RST-SLT graft. In addition, the most common underlying disease was HBV infection in SLT patients. Even with these benefits, ie, shorter ischemia time, younger donor age compared with the other Western studies, and comparable technical proficiency for preserving the entire vasculature to the RTS graft, the OS was worse than that of WL-DDLT. Thus, we should be more cautious in matching the splittable donors and recipients.
